Uncategorized
AstraZeneca Building Shanghai Production Plant to Support Cell Therapy Strategy
The company is establishing commercial production capabilities to fuel plans to launch autologous CAR-T cell therapies in China.
The company is establishing commercial production capabilities to fuel plans to launch autologous CAR-T cell therapies in China.